AREVA Med Launches Production of Lead-212 at New Facility

  AREVA Med Launches Production of Lead-212 at New Facility

Business Wire

PARIS -- November 21, 2013

Regulatory News :

AREVA (Paris:AREVA) :

AREVA Med inaugurated today the Maurice Tubiana Facility located at
Bessines-sur-Gartempe, France (Limousin region). After receiving the
administrative authorizations and completing the prerequisite technical
testing, this unique facility has started production to extract and purify
lead-212 for medical use.

This rare metal is used in the development of innovative treatments for
certain cancers that do not respond to other conventional methods. As
innovation in nuclear medicine is dependent upon the availability of high
purity isotopes, the industrial production of the Maurice Tubiana Facility
will provide sufficient amounts of high-purity lead 212 for clinical
development. Lead-212 is being used currently in an AREVA Med Phase 1 clinical
trial at the University of Alabama at Birmingham in the United States.

Patrick Bourdet, CEO of AREVA Med, said: “This facility, completed thanks to
AREVA’s expertise in radiochemistry and nuclear facility design and the
support of our partners, confirms AREVA Med’s industrial development. This
will allow us to accelerate the development of alpha radio-immunotherapy using
lead-212.”

MORE ABOUT AREVA
AREVA supplies advanced technology solutions for power generation with less
carbon. Its expertise and unwavering insistence on safety, security,
transparency and ethics are setting the standard, and its responsible
development is anchored in a process of continuous improvement.
Ranked first in the global nuclear power industry, AREVA’s unique integrated
offering to utilities covers every stage of the fuel cycle, nuclear reactor
design and construction, and operating services. The group is actively
developing its activities in renewable energies – wind, bioenergy, solar and
energy storage – to become a European leader in this sector.
With these two major offers, AREVA’s 46,000 employees are helping to supply
ever safer, cleaner and more economical energy to the greatest number of
people.

Tour AREVA – 1 Place Jean Millier – 92400 COURBEVOIE – France – Tel: +33 (0)1
34 96 00 00 – Fax: +33 (0)1 34 96 00 01 /1

Contact:

AREVA
Press Office
Julien Duperray
Katherine Berezowskyj
Aurélie Grange
Jérôme Rosso
Alexandre Thébault
T: +33 (0)1 34 96 12 15
press@areva.com
or
Investors Relations
Marie de Scorbiac, T: +33 (0)1 34 96 05 97
marie.descorbiac@areva.com
or
Philippine du Repaire, T: +33 (0)1 34 96 11 51
philippine.durepaire@areva.com
 
Press spacebar to pause and continue. Press esc to stop.